Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

427
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
427
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

84
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
84
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.9K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LacR and TrxB are key virulence factors involved in pneumococcal meningitis as identified by a genome-wide association study.

Communications biology·2026
Same author

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

EBioMedicine·2026
Same author

Autoantibodies in long COVID: A mechanistic foothold in a heterogeneous disease.

Cell·2026
Same author

Neuroinflammation in Ischemic Stroke: Mechanisms, Systemic Interactions, and Therapeutic Targets.

Translational stroke research·2026
Same author

Group B streptococcal disease in infants 0-3 months in The Netherlands, 1987-2023: a nationwide genomic and epidemiological surveillance study.

The Lancet regional health. Europe·2026
Same author

Redefining tissue immunity: lessons from the CNS and beyond.

Current opinion in infectious diseases·2026

Related Experiment Video

Updated: Oct 27, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.4K

Community-acquired bacterial meningitis.

Diederik van de Beek1, Matthijs C Brouwer1, Uwe Koedel2

  • 1Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Meibergdreef, Amsterdam, Netherlands.

Lancet (London, England)
|July 25, 2021
PubMed
Summary

Despite advances in vaccines and treatments, bacterial meningitis remains a global health threat. Early diagnosis and treatment are crucial, but new diagnostic tools and therapies are needed to combat evolving pathogens and resistance.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.5K

Related Experiment Videos

Last Updated: Oct 27, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.4K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.5K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Community-acquired bacterial meningitis presents a significant global health burden despite decades of progress.
  • Vaccines for Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae have reduced incidence, but serotype replacement and antimicrobial resistance pose ongoing challenges.

Purpose of the Study:

  • To review the current status of bacterial meningitis prevention and treatment.
  • To highlight challenges in diagnosis and management.
  • To identify areas for future research and intervention.

Main Methods:

  • Review of recent literature on bacterial meningitis.
  • Analysis of diagnostic approaches including clinical presentation, cerebrospinal fluid analysis, and molecular diagnostics.
  • Evaluation of current and emerging treatment strategies, including antimicrobial therapy and adjunctive treatments.

Main Results:

  • Typical clinical signs of meningitis may be absent, necessitating laboratory confirmation via cerebrospinal fluid analysis.
  • Multiplex PCR point-of-care panels offer potential for rapid diagnosis but require further validation.
  • Early antimicrobial administration (within 1 hour) and adjunctive dexamethasone (in high-income countries) improve outcomes.

Conclusions:

  • Bacterial meningitis continues to be a major health challenge requiring enhanced preventive strategies, particularly new vaccines.
  • Improved hospital protocols for early diagnosis and treatment are essential.
  • Further research into novel therapies targeting the inflammatory cascade is warranted.